Literature DB >> 25882010

Slow-release of famotidine from tablets consisting of chitosan/sulfobutyl ether β-cyclodextrin composites.

Makoto Anraku1, Ayumu Hiraga1, Daisuke Iohara1, James D Pipkin2, Kaneto Uekama3, Fumitoshi Hirayama4.   

Abstract

An intermolecular complex formed from a 1:1 weight ratio of chitosan (CS, molecular weight 30 kDa) and sulfobutyl ether β-cyclodextrin (SBE-β-CyD, degree of substitution 7) was less soluble than either of the original components. The release of famotidine from tablets composed of a simple mixture of CS and SBE-β-CyD is slower in media at pH 1.2 than at 6.8. Macroscopic observation of tablets and a kinetic analysis of release profiles suggested that, at pH 1.2, the drug was slowly released from the less-soluble CS/SBE-β-CyD complex formed on the surface of the tablet immediately after exposure to water, accompanied by the dissolution of the interpolymer complex and, ultimately, the erosion and disintegration of the tablet. In the case of the medium at pH 6.8, the formation of a gel by CS was the cause of the slow release, especially for CS/SBE-β-CyD tablets which were significantly gelated and both the diameter and thickness of the tablet had expanded. The in vitro slow releasing characteristic of the CS/SBE-β-CyD tablet was reflected in the in vivo absorption of the drug after oral administration to rats. These results suggest that a simple mixing of CS and SBE-β-CyD is potentially useful for the controlled release of a drug.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chitosan; Extending release; Famotidine; Interpolymer complex; Release control; Sulfobutyl ether β-cyclodextrin

Mesh:

Substances:

Year:  2015        PMID: 25882010     DOI: 10.1016/j.ijpharm.2015.04.022

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

Review 1.  The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability.

Authors:  Jannes van der Merwe; Jan Steenekamp; Dewald Steyn; Josias Hamman
Journal:  Pharmaceutics       Date:  2020-04-25       Impact factor: 6.321

2.  Cyclodextrin Derivative Enhances the Ophthalmic Delivery of Poorly Soluble Azithromycin.

Authors:  Anil Thakur; Sourabh Jain; Anjali Pant; Akanksha Sharma; Rajiv Kumar; Neha Singla; Ashish Suttee; Santosh Kumar; Ravi P Barnwal; Om Prakash Katare; Gurpal Singh
Journal:  ACS Omega       Date:  2022-06-24

3.  β-cyclodextrin chitosan-based hydrogels with tunable pH-responsive properties for controlled release of acyclovir: design, characterization, safety, and pharmacokinetic evaluation.

Authors:  Nadia Shamshad Malik; Mahmood Ahmad; Mohammed S Alqahtani; Arshad Mahmood; Kashif Barkat; Muhammad Tariq Khan; Ume Ruqia Tulain; Ayesha Rashid
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

Review 4.  Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications.

Authors:  Randy Chi Fai Cheung; Tzi Bun Ng; Jack Ho Wong; Wai Yee Chan
Journal:  Mar Drugs       Date:  2015-08-14       Impact factor: 5.118

5.  Surface-Deacetylated Chitin Nano-Fiber/Hyaluronic Acid Composites as Potential Antioxidative Compounds for Use in Extended-Release Matrix Tablets.

Authors:  Makoto Anraku; Ryo Tabuchi; Shinsuke Ifuku; Takako Ishiguro; Daisuke Iohara; Fumitoshi Hirayama
Journal:  Int J Mol Sci       Date:  2015-10-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.